ResearcherFujita Health UniversityActive in the last 2 years
Senju Hashimoto
Matched on ORCID iD 0000-0002-3581-2004; OpenAlex author ID A5077690667. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper
Papers 7
- Efficacy of 1-Kestose Supplementation in Patients with Pancreatic Ductal Adenocarcinoma: A Randomized Controlled Pilot Study. Co-author DOI 10.3390/nu16172889↗
- Changes in intestinal bacteria and imbalances of metabolites induced in the intestines of pancreatic ductal adenocarcinoma patients in a Japanese population: a… Co-author DOI 10.1080/00365521.2022.2114812↗
- Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/diagnostics13020215↗
- Randomized Phase II Study of Consecutive-Day versus Alternate-Day Treatment with S-1 as Second-Line Chemotherapy in Advanced Pancreatic Cancer. Co-author DOI 10.1159/000492388↗
- Natural history of pancreatic cystic lesions: A multicenter prospective observational study for evaluating the risk of pancreatic cancer. Co-author DOI 10.1111/jgh.13967↗
- The prognostic factors and trajectory of HRQOL in patients with pancreatic cancer who received psychiatric intervention. Co-author DOI 10.1111/jgh.13172↗
- Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresectable pancreatic cancer. Co-author DOI 10.1007/s00280-010-1531-6↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshiki Hirooka · 7 shared papers, 2011–2024 · strength 0.71
- Paper Efficacy of 1-Kestose Supplementation in Patients with Pancreatic Ductal Adenocarcinoma: A Randomized Controlled Pilot … DOI 10.3390/nu16172889↗
- Paper Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.3390/diagnostics13020215↗
- Paper Changes in intestinal bacteria and imbalances of metabolites induced in the intestines of pancreatic ductal adenocarcin… DOI 10.1080/00365521.2022.2114812↗
- Eizaburo Ohno · 6 shared papers, 2011–2024 · strength 0.56
- Paper Efficacy of 1-Kestose Supplementation in Patients with Pancreatic Ductal Adenocarcinoma: A Randomized Controlled Pilot … DOI 10.3390/nu16172889↗
- Paper Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.3390/diagnostics13020215↗
- Paper Randomized Phase II Study of Consecutive-Day versus Alternate-Day Treatment with S-1 as Second-Line Chemotherapy in Adv… DOI 10.1159/000492388↗
- Kazunori Nakaoka · 3 shared papers, 2023–2024 · strength 0.50
- Paper Efficacy of 1-Kestose Supplementation in Patients with Pancreatic Ductal Adenocarcinoma: A Randomized Controlled Pilot … DOI 10.3390/nu16172889↗
- Paper Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.3390/diagnostics13020215↗
- Paper Changes in intestinal bacteria and imbalances of metabolites induced in the intestines of pancreatic ductal adenocarcin… DOI 10.1080/00365521.2022.2114812↗
- Takuya Ishikawa · 3 shared papers, 2018–2023 · strength 0.30
- Paper Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.3390/diagnostics13020215↗
- Paper Randomized Phase II Study of Consecutive-Day versus Alternate-Day Treatment with S-1 as Second-Line Chemotherapy in Adv… DOI 10.1159/000492388↗
- Paper Natural history of pancreatic cystic lesions: A multicenter prospective observational study for evaluating the risk of … DOI 10.1111/jgh.13967↗
- Hiroki Kawashima · 4 shared papers, 2011–2023 · strength 0.29
- Paper Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.3390/diagnostics13020215↗
- Paper Randomized Phase II Study of Consecutive-Day versus Alternate-Day Treatment with S-1 as Second-Line Chemotherapy in Adv… DOI 10.1159/000492388↗
- Paper The prognostic factors and trajectory of HRQOL in patients with pancreatic cancer who received psychiatric intervention. DOI 10.1111/jgh.13172↗
- Hidemi Goto · 3 shared papers, 2011–2018 · strength 0.13
- Paper Natural history of pancreatic cystic lesions: A multicenter prospective observational study for evaluating the risk of … DOI 10.1111/jgh.13967↗
- Paper The prognostic factors and trajectory of HRQOL in patients with pancreatic cancer who received psychiatric intervention. DOI 10.1111/jgh.13172↗
- Paper Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresec… DOI 10.1007/s00280-010-1531-6↗
- Hiroyuki Sugimoto · 2 shared papers, 2016–2018 · strength 0.11
- Akihiro Ito · 1 shared paper, 2011 · strength 0.02
- Kazuo Hara · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.